![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-218x150.jpeg "Genetic Link between Alzheimer’s and Brain Inflammation Found")
Genetic Link between Alzheimer’s and Brain Inflammation Found
Alzheimer’s Disease (AD) is a notorious death valley for drug discovery, with more than 100 candidate drugs having failed in clinical trials so far....
Gilead Launches Sequencing Spree After Phase III NASH Flop
Gilead Sciences is turning to gene sequencing to refresh its nonalcoholic steatohepatitis (NASH) pipeline. The company is collaborating with Renown Institute for Health Innovation...
FDA Clears iCubate’s iC-GN Assay for Bloodstream Infection and Subsequent Sepsis
Syndromic test developer iCubate has won FDA clearance for its ic-GN Assay, a qualitative, multiplexed, in vitro diagnostic test designed to detect and identify...
Day Zero Diagnostics Awarded Phase I SBIR Grant for Algorithm Development
Day Zero Diagnostics (DZD) said today it has received a Phase I Small Business Innovation Research (SBIR) award from the NIH’s National Institute of...
Therapy Targeting Gene Associated with Psychosis Alleviates Symptoms
Treating psychosis by targeting a genetic mutation alleviates symptoms. That’s according to a new, proof-of-principle study that just may pave the way for precision...
Interpace Diagnostics Buys Cancer Genetics’ BioPharma Business for $23.5M
Interpace Diagnostics Group has acquired the BioPharma services business of Cancer Genetics for approximately $23.5 million, while concurrently the buyer will receive a $27...
GNS Healthcare Closes $23M Series D Finance Round
Artificial intelligence-powered precision medicine company GNS Healthcare has announced a $23 million Series D fundraising round led by Cigna Ventures, a wholly owned indirect...
Study Suggests Target for Aggressive Prostate Cancer Subtype
Researchers have discovered the mechanism by which a recently described subtype of aggressive prostate cancer spreads, even after treatment with next-generation androgen receptor (AR)...
Actionable Type 2 Diabetes Risks Uncovered
More than 67 actionable clinical discoveries were made through deep longitudinal genomic analysis by a group led by Michael Snyder, MD, chair of the...
MGI, Karolinska Institutet Collaborate on Translational Microbiome Research
MGI Tech (MGI), a subsidiary of BGI Group, and Centre for Translational Microbiome Research (CTMR) at Karolinska Institutet, Stockholm today announced a strategy collaboration...
